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Enhancers determine tissue-specific gene expres-
sionprograms.Enhancers aremarkedbyhighhistone
H3 lysine 4 mono-methylation (H3K4me1) and by
the acetyl-transferase p300, which has allowed
genome-wide enhancer identification. However, the
regulatory principles by which subsets of enhancers
become active in specific developmental and/or en-
vironmental contexts are unknown. We exploited
inducible p300 binding to chromatin to identify, and
then mechanistically dissect, enhancers controlling
endotoxin-stimulated gene expression in macro-
phages. In these enhancers, binding sites for the
lineage-restricted and constitutive Ets protein PU.1
coexisted with those for ubiquitous stress-inducible
transcription factors such as NF-kB, IRF, and AP-1.
PU.1 was required for maintaining H3K4me1 at
macrophage-specific enhancers. Reciprocally, ec-
topic expression of PU.1 reactivated these enhancers
in fibroblasts. Thus, the combinatorial assembly of
tissue-andsignal-specific transcription factorsdeter-
mines the activity of a distinct group of enhancers.
We suggest that this may represent a general para-
digm in tissue-restricted and stimulus-responsive
gene regulation.
INTRODUCTION
The vastness and complexity of mammalian genomes is a major
hurdle toward a systematic identification of cis-regulatory
regions. Technological progresses in the identification of tran-
scription start sites (TSS) have improved our ability to locate
promoters (Carninci et al., 2006). Conversely, identification of
distant gene regulatory sequences has until recently almost
exclusively relied on comparative genomics and specifically on
the identification of evolutionarily conserved extra- and intra-
genic noncoding sequences (Boffelli et al., 2003; Prabhakaret al., 2006). Comparative approaches to enhancer mapping
successfully led to the identification of many functional
enhancers, which included several ultraconserved elements
(Pennacchio et al., 2006; Visel et al., 2008), namely short extra-
genic regions identical between the human and rodent genomes
(Bejerano et al., 2004; Katzman et al., 2007). However, these
approaches suffer from important limitations; for instance,
regulatory sequences controlling environmental responses (like
immune response to pathogens and stress responses in general)
evolved rapidly togetherwith the associated genes (which under-
went frequent duplications and losses) (Ponting, 2008). There-
fore, although regulatory sequences controlling developmental
genes tend to be highly conserved, those associated with envi-
ronmental genes are believed to be less evolutionarily con-
strained. Overall, a sizable fraction of functional noncoding
sequences involved in gene regulation are lineage specific
and not particularly conserved across mammals (Birney et al.,
2007). Moreover, evolutionary conservation does not allow
predicting in which tissue(s) or condition(s) a given enhancer is
active (Visel et al., 2009). A major advance toward systematic
enhancer mapping has been the identification of a specific
enhancer-associated chromatin signature consisting in a broad
(several kilobases-long) domain of histone H3K4 monomethyla-
tion (H3K4me1) combined with low amounts of H3K4me3 (a
modification associated with the TSSs of active or poised genes)
(Heintzman et al., 2007). H3K4me1hi/H3K4me3lo domains are
also frequently bound by the histone acetyltransferase and tran-
scriptional coregulator p300 (Heintzman et al., 2007). Because
p300-bound regions within H3K4me1hi/H3K4me3lo domains
are narrow, they are particularly useful in spotting core enhancer
sequences (Heintzman et al., 2009; Visel et al., 2009). In spite of
these progresses, our current understanding of the genomic
determinants of enhancer activity and of how enhancers become
functional in specific cellular and/or environmental contexts is still
rudimentary and can be summarized in the broad concept that
enhancers contain heterotypic clusters of transcription factor
binding sites (TFBSs) that work in a cell-type-specific fashion.
The objective of this study was to determine the regulatory
logic of a discrete set of enhancers involved in a paradigmatic
context-dependent environmental response, endotoxin-induced
gene activation in macrophages. Innate immune responses toImmunity 32, 317–328, March 26, 2010 ª2010 Elsevier Inc. 317
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activated both in professional innate immune cells such as
neutrophils andmacrophages and tissue cells coming in contact
with microbes. Although genes induced in response to microbial
challenge in professional and nonprofessional innate immune
cells extensively overlap, there are important qualitative and
quantitative differences. For instance, production of the T helper
1 (Th1) cell-polarizing cytokine IL-12 is restricted to macro-
phages and dendritic cells, even though this gene depends on
an NF-kB protein (cRel) (Sanjabi et al., 2000) that is expressed
in other immune (B and T lymphocytes) and nonimmune cells
(e.g., fibroblasts) (Hayden et al., 2006). The gene encoding
TNF-a, a major mediator of inflammation, is expressed by
several cell types but at amounts that are orders of magnitude
lower than those found in macrophages (Tracey and Cerami,
1994). Therefore, although it is clear that the cellular context
strongly impacts on the inflammatory gene expression program
(and on stress responses in general), the underlyingmechanisms
are largely ignored.
The datawe obtained demonstrate that a common occurrence
in endotoxin-activated enhancers in macrophages is the hetero-
typic clustering of functional binding sites for one or more cell-
type-restricted and constitutive TFs (which provide context-
dependence) and ubiquitous stress-inducible TFs (which enable
responsiveness to environmental stimuli). These data enhance
our understanding of the mechanisms controlling inflammatory
responses at the transcriptional level and may suggest a general
paradigm of how context-dependent inducible gene expression
programs are encoded in the underlying genome.
RESULTS
Inducible Binding of p300 to Enhancers Activated
by Inflammatory Stimuli
Given that enhancers were previously found to be constitutively
associated with both p300 and the H3K4me1hi/H3K4me3lo
signature in the cell types and experimental conditions
analyzed (Heintzman et al., 2009), we investigated by chromatin
immunoprecipitation (ChIP) whether lipopolysaccharide (LPS)
stimulation affects p300 binding and/or H3K4me1 association
at a well-characterized intronic enhancer controlling inducible
expression of Sod2 (encoding the manganese superoxide
dismutase) (Jones et al., 1997). Although the intronic Sod2
enhancer was constitutively associated with H3K4me1, it
recruited p300 only in response to LPS stimulation (Figure 1A).
LPS-induced binding of the NF-kB subunit p65, an essential
regulator of inflammatory gene expression (Hayden et al.,
2006), paralleled p300 recruitment. Therefore, we exploited the
inducible binding of p300 to chromatin to identify putative cis-
regulatory regions involved in LPS-stimulated gene expression.
Anti-p300 ChIP was carried out on formaldehyde-crosslinked
chromatin obtained from untreated and LPS-treated (2 hr)
bone marrow-derived mouse macrophages and immunoprecip-
itated DNA was subjected to massively parallel sequencing. We
detected 2742 peaks (‘‘inducible peaks’’; Table S1 available
online) that were increased by LPS stimulation at high statistical
significance (p < 106; see Experimental Procedures). A small
fraction of these peaks (310/2742; 11.3%) was already detect-
able in unstimulated macrophages, but the majority of them318 Immunity 32, 317–328, March 26, 2010 ª2010 Elsevier Inc.(2432/2742; 88.7%) appeared only after treatment. We also
detected 8064 p300 peaks in untreated macrophages, which
were not increased by LPS treatment (‘‘noninducible’’ peaks;
Table S1). Validation by standard ChIP and quantitative PCR
(ChIP-QPCR) of random peaks with a broad range of associated
p values confirmed the sequencing results in both groups
(Figure S1). The distribution of inducible p300 peaks relative to
genes in the University of California Santa Cruz (UCSC) Known
Genes data set was consistent with previous reports (Heintzman
et al., 2009; Visel et al., 2009), with a strong representation of
intergenic and intronic sequences (56% and 27% respectively;
Figure 1B). Twenty-nine percent of extragenic peaks were
located within 20 kb from annotated TSS and 73% were within
100 kb (Figure 1B). The intragenic peaks were often close
to the TSS (44% within 20 kb), consistent with the common
occurrence of enhancers in introns at the 50 of genes, but a large
fraction of them was located at much larger distances. The 392
inducible p300 peaks associated with promoters and adjacent
regions (±2.5 kb surrounding TSSs of UCSC known genes)
were excluded from further analyses and our experimental
data set of putative enhancers involved in LPS-induced gene
expression eventually consisted in 2350 TSS-distal regions
(1519 intergenic and 831 intragenic sequences).
Using publicly available microarray data, we first evaluated
whether inducible p300 peaks are associated with genes whose
expression is increased by LPS stimulation. To this aim, we
tentatively assigned p300 peaks to individual genes. To reason-
ably limit arbitrariness in gene assignment, we considered only
intragenic peaks between +2.5 and +20 kb and intergenic
peaks located between 2.5 kb and 20 kb from a mapped
TSS and we linked them to the corresponding genes. When
compared to a control group consisting of all the RefSeq
genes mappable to probes in the microarray, the set of genes
associated with inducible p300 binding was enriched for LPS-
stimulated transcripts at high statistical significance (p < 1016
in a chi-square test) (Figure 1C), thus providing initial correlative
evidence that inducible binding of p300 marks regulatory
regions associated with LPS-stimulated genes. Importantly,
genes associated with enhancers bound by p300 in an LPS-
inducible manner belonged to several classes of LPS-respon-
sive genes (primary, secondary, promiscuously, and selectively
activated genes) (Ramirez-Carrozzi et al., 2009), without any
obvious specificity. Some representative regions are shown in
Figure 1D, including the Sod2 intronic enhancer, an intergenic
region upstream of the genic cluster containing the tumor
necrosis factor alpha (Tnfa) and the lymphotoxin alpha (Lta)
genes, and the genomic region including the housekeeping
beta-actin (Actb) gene, which contains only noninducible p300
peaks. Thus, inducible p300 binding can be used for mapping
potential enhancers activated in response to macrophage
stimulation.
Sites of Inducible p300 Binding Have
an Enhancer-Associated Chromatin Signature
Wenext set out to determine whether the regions identified in the
p300 ChIP-sequencing screening have properties of bona fide
enhancers in terms of chromatin signature, sequence conserva-
tion, presence of functional TFBSs, and ability to drive macro-
phage-restricted LPS-inducible gene expression.
Figure 1. LPS Induces Binding of p300 to Potential Regulatory Sequences in Mouse Macrophages
(A) Inducible binding of p300 to the Sod2 intronic enhancer in mouse macrophages. The position of the Sod2 intronic enhancer is shown in the scheme together
with the mapped TFBSs. ChIP was carried out with H3K4me1, p300, and p65 NF-kB antibodies. Data are expressed as percent of the input.
(B) Genomic distribution of LPS-inducible p300 peaks relative to UCSC known genes.
(C) Association of inducible p300 peaks with genes activated by LPS stimulation. Inducible p300 peaks between 2.5 and 20 kb and between +2.5 and +20kb
frommapped TSSswere assigned to the associated genes. The fraction of these genes induced (fold changeR 1.5), unchanged, or repressed in response to LPS
stimulation is shown. For comparison, a control set including all RefSeq genes in the microarray was used. The difference between the two groups is statistically
significant (p < 1016).
(D) Raw p300 ChIP-Seq data at three representative genomic regions. Inducible p300 peaks are highlighted in green.
Immunity
Inflammatory Gene Enhancers in MacrophagesWe first generated a data set of H3K4me1-associated
sequences in unstimulated macrophages and cross-compared
it to the inducible p300 data set and to an H3K4me3 data set
we recently obtained in the same cellular system (De Santa
et al., 2009). We also generated an H3K4me1 data set after
LPSstimulation, but datawere substantially identical to thoseob-
tained in unstimulated conditions, indicating a poor reactivity of
this histonemark to environmental stimuli (data not shown). Distal
p300 peaks were in most cases contained within H3K4me1hi/
H3K4me3lo domains (Figure 2), thus suggesting that the chro-
matin environment surrounding regions of LPS-inducible p300
binding is similar to the one previously described in functional
enhancers. Interestingly, the central sequences (250–300 nt)
within H3K4me1 regions (corresponding to the p300 peaks,
around which these regions were aligned) were frequently
depleted of H3K4me1, whichmay indicate selective nucleosomeeviction (Figure 2 andFigureS2).Only a small fraction of inducible
p300 peaks resided outside of H3K4me1hi/H3K4me3lo domains,
a result in keeping with previous observations in transformed cell
lines (Heintzman et al., 2007). Overall, distal regions bound by
p300 in response to LPS stimulation were associated with the
classical chromatin signature of enhancers.
Sequence Conservation and Ultraconservation
at Inflammatory Enhancers
Regulatory elements within enhancers are subjected to purifying
selection, even though a substantial fraction of regulatory DNA
lacks detectable sequence constraints (Birney et al., 2007;
Ponting, 2008). To determine the degree of conservation in the
sequences bound by p300 in an inducible manner, we first
scored the presence of stretches conserved across 20 placental
mammalian genomes with the phastCons program (SiepelImmunity 32, 317–328, March 26, 2010 ª2010 Elsevier Inc. 319
Figure 2. Inducible p300 Peaks Occur in Regions with a Chromatin
Signature of Enhancers
H3K4me1 and H3K4me3 state at p300 peaks. ChIP-Sequencing data
obtained with H3K4me1 and H3K4me3 antibodies in untreated macrophages
were used for identifying the enhancer chromatin signature at LPS-inducible
distal peaks. Each line represents a p300 peak. Regions (5 kb) were centered
on the summit of the p300 peaks. The upper panel refers to the 2350 distal
(intergenic and intragenic p300 peaks), whereas lower panel refers to the
392 inducible p300 peaks located ±2.5 kb from the TSSs of UCSC known
genes.
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Inflammatory Gene Enhancers in Macrophageset al., 2005), which detects sequence conservation in a fraction
between 2.8% and 8.1% of the human genome (depending on
the parameters used). This analysis (Figure 3A and Table S1)
revealed that distal regions associated with inducible p300
binding contain sequence elements under evolutionary conser-
vation. When considering 5 kb windows surrounding inducible
p300 peaks, conserved elements were clearly clustered in
the central regions, corresponding to the sequences contacted
by p300 (Figure 3A). Association with evolutionary conserved
sequence elements was statistically significant when compared
to random genomic sets (Figure 3A, right panel). We next
analyzed the correlation between high degree of sequence
conservation and p300 binding using a database of 171,853
human-rodent highly conserved noncoding sequences (CNSs)
(Prabhakar et al., 2006), corresponding to 2.3% of the mouse
genome. We found that 242/2350 (10.3%) inducible and distal
p300 peaks overlapped these CNSs. To determine the statistical
significance of this finding, we first calculated the overlap of
inducible p300 peaks (Figure 3B, red line) with CNSs at different
cutoffs of p values (Prabhakar et al., 2006). We then generated
1000 random sets of sequences with the same genomic compo-320 Immunity 32, 317–328, March 26, 2010 ª2010 Elsevier Inc.sition and derived a distribution (boxes) of expected overlap
values for each cutoff of CNSs p values. This way we calculated
the probability (p) that the observed values are significantly
different from the expected distribution. Association of inducible
p300 peaks with CNSs was statistically significant (p% 0.01) for
CNSs with cutoff values higher than a p value % 1010 (Fig-
ure 3B). It is important to notice that statistical significance is
lost when elements with an extreme degree of evolutionary
conservation (those at the right side of the graph) are considered.
These ultraconserved elements, which are subjected to strong
purifying selection (Katzman et al., 2007), frequently correspond
to developmental enhancers (Visel et al., 2008), and it is reason-
able to expect them not to be associated with environmental
genes, whose evolution occurs on a much faster time scale
than that of developmental genes (Ponting, 2008). Overall,
LPS-inducible binding of p300 frequently occurs in regions of
strong (but not extreme) evolutionary conservation. It is also
clear that part of these putative enhancers lack CNSs, a result
consistent with the known evolutionary properties and lineage
specificity of environmental genes (Ponting, 2008).
Functional and Organizational Properties
of Inflammatory Enhancers
We next functionally evaluated some genomic regions bound by
p300 to determine whether they direct macrophage-specific
inducible gene expression. A panel of randomly selected
positive regions (corresponding to peaks with a broad range of
p values) and two negative controls (regions not bound by
p300) were cloned upstream of a minimal promoter driving lucif-
erase expression and transfected in the macrophage cell line
Raw264.7 and in two LPS-sensitive nonmyeloidmouse cell lines,
the hepatoblastoma Hepa1-6, and the melanoma cell line C57/
B1. The p300-bound regions tested (but not the negative control
sequences) increased basal luciferase expression to a various
extent (as compared to the enhancer-less vector) and provided
responsiveness to LPS stimulation in Raw264.7 cells (Figure 4A).
The same sequences were either inactive or much less active
when transfected in the other two cell lines. Overall, the p300-
bound regions identified in the ChIP-Seq screening have a
chromatin signature, a degree of conservation and functional
properties compatible with a role as macrophage-restricted
enhancers involved in LPS-inducible gene expression.We there-
fore set out to investigate the underlying genomic determinants
of their functional properties and specifically of their macro-
phage-restricted inducible activity.
If inducible p300 peaks correspond to enhancers controlling
inflammatory gene expression, an obvious prediction is that
they should be enriched for binding sites for stimulus-activated
TFs required for the deployment of the inflammatory gene
expression program, like NF-kB (Rel) and IRF family members
(Taniguchi et al., 2001; Hayden and Ghosh, 2008). We searched
for TFBS overrepresented in the p300 data set relative to two
reference sets, namely a whole chromosome (mouse chr 19)
and a set of the 5 kb sequences located upstream of the TSSs
of all mouse RefSeq genes. We first assembled a library of
DNA binding motifs consisting of the 138 position weight
matrices (PWMs) in the Jaspar database (Sandelin et al.,
2004) and 208 high quality PWMs (referring to 104 mouse TFs)
recently obtained with protein-binding microarrays containing
Figure 3. Sequence Conservation and Ultracon-
servation at Regions of Inducible p300 Binding
(A) Conserved sequence elements were analyzed with the
phastCons program (Siepel et al., 2005). In the left panel,
average conservation scores (phastCons score per bp)
in the distal, TSS-associated and random groups are
shown. Inducible p300 peaks were centered on their
summit. As shown in the right panel, statistical signifi-
cance of sequence conservation in the two groups was
evaluated as compared to random sets. The y axis indi-
cates the p value of the deviation from random. The hori-
zontal gray line indicates the threshold for statistical
significance (set to p < 0.01).
(B) Enrichment of inducible p300 peaks at previously
annotated conserved noncoding sequences. A database
of 171,853 human-rodent CNSs (Prabhakar et al., 2006)
was overlapped with the 2350 inducible distal p300
peaks or with 1000 random sets composed of an identical
number of sequences of similar length and composition.
The fraction of p300 peaks (red line) and the distribution
of random sequences (boxes) overlapping annotated
CNSs ordered by increasing p values (according to Prab-
hakar et al., 2006) is shown. Association of p300 peaks
with CNSs is highly statistically significant except when
extremely constrained CNSs (right-half of the graph) are
considered.
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motifs were found to be enriched at a p % 0.01 as compared
to both reference sets, including five matrices for NF-kB (Rel)
proteins and four matrices for IRF proteins (Figure 4B and
Table S2). Overall, 54%of the inducible p300 peaks scored posi-
tive for at least two NF-kB (Rel) PWMs and 48%were positive for
at least two IRF PWMs. As predicted by previous data on tran-
scriptional coregulation by NF-kB and IRFs (Doyle et al., 2002),
binding sites for these two TFs co-occur at a subset of regulatory
regions. Moreover, matrices for additional TFs known to regulate
inflammatory gene expression (like FOS and AP-1) (Baud and
Karin, 2001) or differentiation of the myeloid lineage (like MAFB
and RUNX1 or AML1) (Kelly et al., 2000; Nagamura-Inoue
et al., 2001) were retrieved (Figure 4B and Table S2). These
data show that LPS-inducible p300 peaks clearly define a set
of cis-regulatory sequences strongly enriched for inflammatory
and macrophage-restricted TFs, demonstrating the efficiency
of the ChIP-Seq screening we used at retrieving macrophage-
specific inflammatory enhancers.
Probably the most striking finding of this analysis was that the
most enriched TF in the data set was PU.1 (Sfpi1 or Spi1) and its
closely related paralogue SpiB (identified by three different
PWMs) (Figure 4B and Table S2). PU.1 is a hematopoietic TFImmunity 32, 3required for the development of multiple line-
ages (including macrophages, neutrophils, and
B and T cell lymphocytes) (Scott et al., 1994)
and expressed at highest amounts in mature
macrophages (high amounts of PU.1 favoring
development of myeloid cells over alternative
lineages) (Nerlov and Graf, 1998; DeKoter and
Singh, 2000). PU.1 is required not only for
macrophage differentiation but also for tran-
scriptional control of inducible genes in maturemacrophages (Eichbaum et al., 1994; Grove and Plumb, 1993;
Nguyen and Benveniste, 2000). Interestingly, although IRF and
NF-kB matrices generated well-defined clusters indicating
discrete subgroups of enhancers, the PU.1 and SpiB matrices
were broadly enriched all over the data set, suggesting that
association of enhancers with PU.1 may be a rather common
occurrence in macrophages. Regions of inducible p300 binding
containing NF-kB or IRF PWMs very frequently contained asso-
ciated PU.1 binding sites (76% and 78% overlap, respectively).
ChIP-QPCR experiments demonstrated a strong, and most
often constitutive, PU.1 binding to a panel of p300-bound distal
sequences (Figure 4C), suggesting that sites identified in silico
are in fact functional. Mutations of PU.1 binding sites abrogated
both basal and inducible promoter activity in heterologous
reporter assays, indicating that they are essential for enhancer
functionality (Figure 4D).
TheHematopoietic Ets Family Transcription Factor PU.1
Marks Enhancers in Macrophages
To obtain a global view of PU.1 genomic distribution, we gener-
ated two PU.1 ChIP-Seq data sets in untreated and LPS-treated
macrophages (2 hr stimulation). Using an extremely restrictive
threshold of p < 1010, we detected 44,445 peaks in untreated17–328, March 26, 2010 ª2010 Elsevier Inc. 321
Figure 4. Regions of Inducible p300 Binding Are Macrophage-Specific Enhancers Containing Binding Sites for Inflammatory and Macro-
phage-Restricted TFs
(A) Functional assessment of a panel of p300-bound regions and two control regions (NR1 and NR2) with luciferase-based reporter assays in a macrophage cell
line (Raw264.7), a hepatoblastoma line (Hepa1-6), and a melanoma line (C57/B1). Cells were either left untreated or stimulated with LPS for 16 hr before harvest-
ing. pGL3 represents an enhancer-less cloning vector. Numbers on the x axis indicate the peak ID (according to Table S1).
(B) Enrichment for TFBS in the p300 data set. Each vertical column corresponds to an inducible p300 peak. The rows corresponding to selected PWMs are shown
(please refer to Table S2 for the complete data). The overrepresented PWMs are shown as a heat plot after hierarchical clustering. The color gradient indicates the
likelihood ratio (from Clover analysis) describing the probability that each p300 peak contains a given PWM (with random sets for comparison).
(C) Binding of PU.1 to selected p300-associated regions wasmeasured by ChIP-Q-PCR. Data are expressed as percent of the input. Numbers below the columns
indicate the peak ID according to Table S1. Error bars represent mean ± SEM.
(D) Effect of mutations of PU.1 binding sites on enhancer activity in luciferase assays. Three enhancers containing PU.1 sites (numbered according to Table S1)
were mutagenized. Error bars represent mean ± SEM.
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Inflammatory Gene Enhancers in Macrophagesand 43,243 peaks in LPS-treated cells (Table S3). Using ChIP-
QPCR on a group of peaks representative of a broad range
of p values, we confirmed ChIP-Seq data in 95.8% of cases
(23/24; Figure S3A). The two data sets overlapped by more
than 84%, indicating that PU.1 binding is mainly constitutive
and unaffected by stimulation (although at some regions PU.1
association was enhanced by LPS). A total of 24,791 out of the
44,445 PU.1 peaks in the untreated sample (55.8%) scored posi-
tive for all three PU.1 PWMs at high stringency, whereas 42,993
peaks (96.7%) contained at least one of them, demonstrating
both the reliability of the ChIP-Seq data and the fact that recruit-
ment occurs via direct binding to DNA. PU.1 peaks were
frequently associated with intragenic (39% introns and 4%
exons) and extragenic regions (37%); promoters and sequences322 Immunity 32, 317–328, March 26, 2010 ª2010 Elsevier Inc.surrounding TSSs accounted for the remaining 20% of PU.1
peaks (Figure 5A). For the subsequent analyses, peaks associ-
ated with promoters and TSSs (TSS ± 2.5 kb) were filtered out.
49.2% of inducible p300 peaks (1157/2350) in our data set
overlapped distal PU.1 peaks at 2 hr (at the restrictive threshold
of p < 1010), thus indicating that many sites of inducible p300
binding, in addition to containing binding sites for inducible
but non-cell-type-restricted TFs such as NF-kB and IRF, are
constitutively associated with a macrophage-restricted TF
such as PU.1. In other words, PU.1 seems to constitutively
mark genomic regions for inducible binding of LPS-activated
TFs and p300. NF-kB was indeed recruited in a stimulus-regu-
lated manner to regions showing constitutive PU.1 binding (Fig-
ure S3B). Representative screenshots are shown in Figure 5B
Figure 5. The Macrophage-Specific Transcription Factor PU.1 Is Constitutively Bound to Enhancers
(A) Distribution of PU.1 peaks relative to UCSC known genes.
(B) Two representative screenshots showing H3K4me1, inducible p300 binding, and constitutive PU.1 peaks.
(C) Overlap of PU.1 peaks with previously annotated CNSs. The graph shows the fraction of PU.1 peaks in untreated macrophages (red line) and random
sequences (boxes) overlapping annotated CNSs (ordered by increasing p values according to Prabhakar et al., 2006).
(D) Association of PU.1 peaks with regions with a chromatin signature of enhancers. The PU.1 data set from untreated cells was overlapped with the H3K4me1
andH3K4me3 data sets. Each line represents a PU.1 peak. Peaks were ordered according to chromosomal position, from chr1 (top) to chrX (bottom) without prior
clustering. Regions (5 kb) were centered on the summit of the PU.1 peaks.
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a database of CNSs (Prabhakar et al., 2006) indicates that
more than 2500 PU.1-bound, TSS-distal intra- and intergenic
regions are obviously constrained, a frequency that is much
higher than expected for randomly selected sequences (Fig-
ure 5C). As for p300, ultraconserved elements were not enriched
in the PU.1 data set.
We also analyzed TFBS enrichment in the genomic regions
corresponding to 1193 (out of 2350) distal p300 peaks that did
not overlap PU.1 (Figure S4A). This group was strongly enriched
for PWMs for inflammatory TFs (NF-kB, IRF, STAT1, and AP-1),
as well as for lineage-restricted or fate-determining TFs such as
MAFB andRUNX1 (AML1) (Figure S4A). However, only one of the
three PU.1 PWMs was retrieved, indicative of a comparatively
lower enrichment and/or affinity of potential PU.1 sites in this
group. Indeed, when the statistical threshold for PU.1 peak
calling was lowered (from 1010 to 105), 260 additional regions
in this group were found to be associated to PU.1. The existenceof a number of regulatory regions not associated with PU.1,
however, suggests that additional lineage-specific TFs (such
as MAFB) probably contribute to the genomic regulatory land-
scape in macrophages.
We next tested whether the H3K4me1hi/H3K4me3lo signature
is enriched among all the distal (intergenic and intragenic) PU.1-
bound regions (which largely exceed the regions associated with
inducible p300 binding). Most non-promoter-associated PU.1
peaks were contained within H3K4me1hi/H3K4me3lo domains,
thus confirming that PU.1 is preferentially associated with
enhancers in macrophages (Figure 5D). In conclusion, constitu-
tive PU.1 binding in macrophages defines dozens of thousands
of regions with a genomic distribution, chromatin signature,
and evolutionary constraints compatible with their function as
enhancers. The strong preference of a constitutively expressed,
lineage-determining TF like PU.1 for enhancers may contribute
to explain the cell-type specificity of enhancer-associated
function (Heintzman et al., 2009). In keeping with this notion,Immunity 32, 317–328, March 26, 2010 ª2010 Elsevier Inc. 323
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Inflammatory Gene Enhancers in Macrophagesenhancer sequences bound by PU.1 in macrophages were not
PU.1-associated in B lymphocytes and in hematopoietic pro-
genitors (Figure S5).
According to the data described above, regions of inducible
p300 binding define a subgroup of PU.1-associated enhancers.
Such regions,whensearchedagainstbackgroundsetsof random
genomic sequences, are enriched in binding sites for inflamma-
tory TFs (see Figure 4B). Therefore we examined whether they
are also different from the pool of all distal PU.1-bound regions
in terms of TFBS composition. When the distal PU.1 peaks were
used as a background set, the inducible p300 data set was
enriched for NF-kB, IRF, and FOS-AP1 sites (Figure S4B and
Table S4), indicating that inducible p300 binding identifies a
subgroup of PU.1-associated enhancers that is specifically
enriched in binding sites for essential inflammatory TFs.
An Active Role for PU.1 in Enhancer Organization
The extensive overlap between PU.1 and enhancers in macro-
phages suggests the possibility that PU.1 may directly impart
properties of enhancers to the genomic regions to which it is
recruited. To directly test this possibility, we first analyzed the
effects of PU.1 depletion in primary macrophages. Although
global H3K4me1 amounts were unaffected, several enhancers
in both the inducible and noninducible groups showed various
degrees of H3K4me1 reduction (Figures 6A and 6B). Lack of
effects on other enhancers may reflect redundancy or, more
trivially, the activity of the residual amount of PU.1 in depleted
cells (Figure 6C). Given these data, we considered the possibility
that ectopic expression of PU.1 may drive de novo formation of
enhancers in nonhematopoietic cells, which would be consistent
with the reported ability of PU.1 to partially convert fibroblasts
into macrophages (Feng et al., 2008). As described, retroviral
expression of PU.1 in 3T3 cells was sufficient to induce the upre-
gulation of some macrophage-restricted genes (Figure 6D) like
Cd68, Emr1, and Lyz2, some of them being much stronger
induced upon coexpression of C/EBPa (Feng et al., 2008) (data
not shown). Ectopically expressed PU.1 bound to genomic
regions corresponding to macrophage enhancers (Figure 6E),
and recruitment was associated with a several-fold increase in
H3K4me1 (Figure 6F). Moreover, the regions bound by PU.1
upon overexpression in 3T3 cells acquired properties of nucleo-
some-depleted chromatin similar to those constitutively shown
by the same regions in macrophages (Figures 6G and 6H). This
latter result indicates that nucleosome depletion in enhancers
(Figure 2 and Figure S2) is caused, and maintained by, constitu-
tive TF binding (rather than representing a default state caused
by the inability of these sequences to assemble nucleosomes).
DISCUSSION
The recent identification of a chromatin signature characteristic
of enhancers, together with the recognition that enhancers are
bound by histone acetyltransferases (Heintzman et al., 2007),
enabled large-scale approaches to enhancer mapping in
multiple cell types (Heintzman et al., 2009; Visel et al., 2009).
However, unraveling the complex repertoire of enhancers
present in a given cell type (‘‘enhanceomes’’) in order to identify
functionally homogeneous discrete subgroups active in specific
responses is still a major challenge. Moreover, apart from anec-324 Immunity 32, 317–328, March 26, 2010 ª2010 Elsevier Inc.dotal descriptions, the genomic determinants of enhancer func-
tion are still largely unknown.
The objective of this study was the identification of the organi-
zational principles of enhancers controlling a prototypical envi-
ronmental response influenced by the cellular context, namely
the endotoxin-induced inflammatory gene expression program
in macrophages. Our data showed that LPS-inducible binding
of p300 to chromatin can be exploited to identify enhancers
associated with inducible genes. Analysis of the underlying
genomic sequences allowed us to find a common, intuitive and
highly rational regulatory logic, consisting in the combination of
binding sites for one or more cell-type restricted and constitutive
TFs (particularly PU.1, but also MAFB and RUNX1) with binding
sites for ubiquitous and stimulus-activated TFs like NF-kB, IRF,
and AP1. We suggest that this organization allows the response
induced by inflammatory stimuli to be adapted to the specific
cellular context in which it is elicited. We envision that this archi-
tectural principle may hold true also for enhancers involved in
other types of stress responses. Moreover, the requirement for
PU.1 for maintenance of H3K4me1 at several enhancers in
macrophages, and its ability to locally increase H3K4me1 and
accessibility upon ectopic expression, suggests that PU.1 may
be both required and sufficient to functionalize genomic regions
as enhancers. This property may explain its ability to convert
fibroblasts into macrophages (Feng et al., 2008), and more in
general allows hypothesizing that several fate-determining TFs
may rewire transcriptional circuits largely by inducing formation
of novel enhancers. Because PU.1 extensively marks active
promoters in addition to enhancers, and because distant regula-
tory regions are brought in physical proximity to promoters and
TSSs by looping out the intervening genomic regions, an exciting
scenario is that PU.1 may pervasively contribute to shape the 3D
landscape of the macrophage genome, in fact acting as a global
genomic organizer.
The data described here also raise two groups of questions.
First, what are the regulatory genomic regions involved in the
transcriptional response to the same stimulus (LPS) in cell types
other than macrophages? Our model suggests that functionali-
zation of specific genomic regions as enhancers depends on
tissue-restricted TFs like PU.1, which are characterized by a
capillary genomic distribution and the ability to generate nucleo-
some-free, accessible stretches of DNA sequence: therefore,
a prediction of the model is that in other cell types, the regulatory
landscape will be determined and maintained by TFs with
a different genomic distribution, leading to the usage of distinct
genomic regions in response to the same stimulus. Alternative
usage of the available regulatory information contained in the
genome when different cells are exposed to the same stimulus
would represent the molecular basis for specialized responses
to identical environmental inputs. Second, how do unrelated
inflammatory stimuli (e.g., TNF or IL1) exploit the regulatory
genomic information within the global landscape provided by
PU.1 (or equivalent master regulators in different cell types)?
The simplest possibility is that usage of the vast array of available
regulatory regions (that are kept functional and accessible by
PU.1) will largely or exclusively depend on the specific set of
TFs induced or activated by each individual stimulus, thus
leading to both overlapping and stimulus-specific utilization of
the accessible genomic regulatory information.
Figure 6. PU.1 Controls H3K4me1 at Its Genomic Binding Sites
(A) H3K4me1 ChIP in bone marrow-derived macrophages transfected with either a control (scrambled) siRNA or a mixture of PU.1-specific siRNAs. Data are
expressed as percent of H3K4me1 measured in cells exposed to control siRNA. Peaks IDs refer to Table S1 (I, Inducible peaks; N, noninducible peaks). Error
bars represent means ± SEM.
(B) Total H3K4me1 amounts in PU.1-depleted macrophages. Tubulin was used as a loading control.
(C) PU.1 expression in control and PU.1-siRNA cells were measured by Q-PCR.
(D) Retroviral expression of PU.1 in fibroblasts induces the expression of macrophage markers. Error bars represent mean ± SD.
(E) PU.1 ChIP was carried out on 3T3 fibroblasts infected with a control retrovirus (MSCV-GFP) or a PU.1-EGFP-expressing retrovirus (MSCV-PU.1). Cells
were subjected to four rounds of infection over 2 days and harvested at the fifth day after the last infection. Infection efficiency was >95%. Error bars represent
means ± SEM.
(F) H3K4me1 ChIP on the same samples. See Table S1 for genomic locations of the indicated peaks. Error bars: means ± SEM.
(G) FAIRE (formaldehyde-assisted isolation of regulatory elements) (Giresi et al., 2007) was used for isolating accessible, nucleosome-depleted DNA frommacro-
phages and 3T3 cells. Error bars represent means ± SEM.
(H) FAIRE analysis on 3T3 cells infected with a control virus or with the PU.1-expressing virus. Signal is shown as percent of input. HoxA and beta-Actin promoters
are non-PU.1 targets with a constitutively silent or active chromatin configuration, respectively. Error bars represent means ± SEM.
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Inflammatory Gene Enhancers in MacrophagesThe observation that p300 is recruited to cis-regulatory
regions in response to stimulation is unexpected in the light of
previous ChIP-chip data in human transformed cell lines (Heintz-
man et al., 2007; Heintzman et al., 2009). In these studies it was
shown that both H3K4me1 and p300 constitutively mark sites for
inducible recruitment of the IFN-g-activated TF Stat1. Althoughat a superficial analysis our results (and specifically the observa-
tion that p300 binding is often inducible) may appear to be in
conflict with the data reported in those studies, in fact this is
only partially true. First, we also detected constitutive p300
binding at regions adjacent to many inducible genes, and a frac-
tion of the inducible p300 peaks we found could already beImmunity 32, 317–328, March 26, 2010 ª2010 Elsevier Inc. 325
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Inflammatory Gene Enhancers in Macrophagesdetected in basal conditions. Second, in the experiments by
Heintzman et al. a very short stimulation with IFN-g was used
(20min) (Heintzman et al., 2007; Heintzman et al., 2009), implying
that transcriptional events occurring with slower kinetics were
overlooked. Third, regulatory circuits operating in primary, highly
differentiated and specialized cells like macrophages may be
lost in transformed and continuously cultured cell lines. Finally,
it should be stressed that the notion that p300 can be recruited
to chromatin in a stimulus-regulated manner is consistent with
experimental data accumulated over several years and demon-
strates that p300 is recruited to chromatin by association with
TFs activated by environmental stimuli, including members
of the NF-kB, IRF, and AP-1 families (Zhong et al., 1998; Hottiger
et al., 1998; Merika et al., 1998; Lin et al., 1999; Kamei et al.,
1996; Vanden Berghe et al., 1999; Lin et al., 2001; Wathelet
et al., 1998).
In conclusion, this study demonstrates howa specific genomic
organization at a functionally related group of enhancers is
directly translated into function. The combination of binding sites
for a cell type-restricted constitutive TF (which provide context-
dependence to the response) and binding sites for ubiquitous
inducible TFs (which provide responsiveness to external stimuli),
probably represent a general framework for genomic regulatory
regions controlling specialized reactions to external stimuli.
EXPERIMENTAL PROCEDURES
Cell Culture
Bone marrow cells isolated from female Fvb/Hsd mice were plated in 10 cm
plates in 5 ml of BM-medium (high glucose DMEM supplemented with 20%
lowendotoxin fetal bovine serum, 30% L929-conditioned medium, 1% gluta-
mine, 1%, Pen/Strep, 0.5% sodium pyruvate, and 0.1% b-mercaptoethanol).
Cultures were fed with 2.5 ml of fresh medium every 2 days. Stimulations were
carried out at day 7. RAW 264.7 (mouse macrophage cells), Hepa 1-6 (mouse
hepatoma cells), and EML (clone 1) were purchased from the American Type
Culture Collection (ATCC). A20 cells were a gift from S. Casola. Cells were
grown in Dulbecco minimal essential medium (DMEM) containing 10% fetal
bovine serum (FBS) and 2 mM glutamine. EML1 cells were grown in the pres-
ence of SCF (100 ng/ml). C57/B1 (mouse melanoma epithelial cells) from
ATCC were grown in MEM + 10% FBS supplemented with 2 mM glutamine,
1 mM sodium pyruvate, and 0.1 mM non essential amino acids (NEAA). LPS
from E. Coli serotype EH100 (Alexis) was used at 10 ng/ml.
Chromatin Immunoprecipitation
For ChIP experiments, bonemarrowmacrophages were left untreated or stim-
ulated for 2 hr with LPS. Fixation with formaldehyde and sonication was carried
out as described previously (De Santa et al., 2007). p300, H3K4me1,
H3K4me3, and Pu.1ChIP lysates were generated from 23 108, 0.53 108 cells,
13 108, and 0.33 108 cells respectively. Each lysate was immunoprecipitated
with 10 mg of the following antibodies: p300 (Santa Cruz sc-585), p65
(Santa Cruz sc-372), antiH3K4me1 (Abcam Ab8895), antiH3K4me3 (Abcam
Ab8580), and PU.1 (Santa Cruz sc-352).
Antibodies were prebound overnight to 100 ml of G protein-coupled para-
magnetic beads (Dynabeads) in PBS/BSA 0.5%. Beads were then added to
lysates (the preclearing step was omitted), and incubation was allowed to
proceed overnight. Beads were washed six times in a modified RIPA buffer
(50 mM HEPES [pH 7.6], 500 mM LiCl, 1 mM EDTA, 1% NP-40, and 0.7%
Na-deoxycholate) and once in TE containing 50 mM NaCl. DNA was eluted
in TE containing 2% SDS and crosslinks reversed by incubation overnight at
65C. DNA was then purified by Qiaquick columns (QIAGEN) and quantified
with PicoGreen (Invitrogen). Yields were 10 ng/108 cells (p300), 200 ng/108
cells (H3K4me1), 300 ng/108 cells (H3K4me3), and 250 ng/108 cells
(Pu.1). For p300, two independent biological replicates were used. For valida-
tion by ChIP-QPCR, 1 ml of purified DNA was used for amplified on an Applied326 Immunity 32, 317–328, March 26, 2010 ª2010 Elsevier Inc.Biosystems 7500 Fast Real-time PCR system (with Applied Biosystem Sybr-
green). Primers used for ChIP QPCR are in Table S5.
Preparation of ChIP DNA Libraries, Sequencing,
and Computational Analysis
A detailed description of the ChIP-Sequencing methods and the computa-
tional analyses is provided in the Supplemental Experimental Procedures.
Statistics referring to the sequencing runs are in Table S6.
Transient Transfections, Reporter Assays, RNAi,
and Retroviral Infections
RAW264.7, Hepa 1-6, and C57/B1 cells were transiently transfected in
a 24-well format with 0.8 mg of empty vector (pGL3-promoter vector, Promega)
or vectors containing the specified genomic regions (Table S5) with Lipofect-
amine 2000 (Invitrogen) in accordance with the manufacturer’s protocol.
Twenty-four hours after transfection, cells were treated with LPS (10 ng/ml),
and luciferase assay (Bright-Glo Luciferase Assay System, Promega) was
performed 16 hr after treatment. Values are expressed as n-fold increase in
luciferase counts over the empty vector for each cell line. For siRNA experi-
ments, bone marrow-derived macrophages were transfected with control or
smartpool siRNAs (100 nM, Dharmacon) directed against PU.1 with lipofect-
amine 2000 (Invitrogen). Cells were used for ChIP experiments after 48 hr,
and target gene knockdown was validated by QPCR. 3T3 cells (a gift from
Alex Hoffman, UCSD) were infected with MSCV-IRES-GFP or MSCV-IRES-
PU.1-GFP, as described (Feng et al., 2008). Cells underwent four cycles of
infection over 2 days and were collected 5 days after the last infection. For
the FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) experi-
ment (Giresi et al., 2007), cells were crosslinked and sonicated as for ChIP
experiments. DNA from bone marrow macrophages (1 3 108 cells), 3T3 cells
(1 3 108 cells), 3T3 infected with MSCV-IRES-GFP, or MSCV-IRES-PU.1-
GFP (13 107 cells) was isolated by addition of an equal volume of phenol-chlo-
roform. Before extraction, 50 ml of the lysate were kept as input. The aqueous
phase was isolated and both inputs and samples were subjected to cross-link
reversal at 65C overnight after addition of SDS. DNA was then purified with
Qiaquick columns and subjected to QPCR analysis.
ACCESSION NUMBERS
The ChIP-Seq data sets are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE19553.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, six tables, and Supplemental
Experimental Procedures and can be found with this article online at
doi:10.1016/j.immuni.2010.02.008.
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